Approach to differentiating lesions (neuromuscular junction): Clinical sciences

Last updated: January 30, 2025

Approach to differentiating lesions (neuromuscular junction): Clinical sciences

CAT 5

CAT 5

Approach to differentiating lesions (brainstem): Clinical sciences
Approach to differentiating lesions (cerebellum): Clinical sciences
Approach to differentiating lesions (cerebral cortical and subcortical structures): Clinical sciences
Approach to differentiating lesions (motor neuron): Clinical sciences
Approach to differentiating lesions (muscle): Clinical sciences
Approach to differentiating lesions (nerve root, plexus, and peripheral nerve): Clinical sciences
Approach to differentiating lesions (neuromuscular junction): Clinical sciences
Approach to differentiating lesions (spinal cord): Clinical sciences
Approach to diplopia: Clinical sciences
Idiopathic intracranial hypertension: Clinical sciences
Multiple sclerosis: Clinical sciences
Myasthenia gravis: Clinical sciences
Approach to dysarthria or dysphagia: Clinical sciences
Guillain-Barré syndrome: Clinical sciences
Approach to gradual cognitive decline: Clinical sciences
Alzheimer disease: Clinical sciences
Parkinson disease and dementia with Lewy bodies: Clinical sciences
Approach to headache or facial pain: Clinical sciences
Primary headaches (tension, migraine, and cluster): Clinical sciences
Subarachnoid hemorrhage: Clinical sciences
Temporal arteritis: Clinical sciences
Approach to involuntary movements: Clinical sciences
Approach to tremor: Clinical sciences
Approach to medication-induced movement disorders: Clinical sciences
Approach to urinary incontinence (GYN): Clinical sciences
Stress, urge, overflow, and mixed urinary incontinence (GYN): Clinical sciences
Urinary retention: Clinical sciences
Approach to weakness (focal and generalized): Clinical sciences
Acute stroke (ischemic or hemorrhagic) or TIA: Clinical sciences
Approach to altered mental status: Clinical sciences
Delirium: Clinical sciences
Approach to aphasia: Clinical sciences
Approach to dizziness and vertigo: Clinical sciences
Approach to back pain: Clinical sciences
Approach to unsteadiness, gait disturbance, or falls: Clinical sciences
Approach to acute vision loss: Clinical sciences
Approach to blunt cerebrovascular injury: Clinical sciences
Approach to convulsive status epilepticus: Clinical sciences
Approach to encephalitis: Clinical sciences
Approach to encephalopathy (acute and subacute): Clinical sciences
Approach to increased intracranial pressure: Clinical sciences
Approach to traumatic brain injury (pediatrics): Clinical sciences
Approach to traumatic brain injury: Clinical sciences
Brain death: Clinical sciences
Hepatic encephalopathy: Clinical sciences
Meningitis and brain abscess: Clinical sciences
Uremic encephalopathy: Clinical sciences
Approach to compressive mononeuropathies: Clinical sciences
Approach to epilepsy: Clinical sciences
Approach to facial palsy: Clinical sciences
Approach to polyneuropathy: Clinical sciences
Inflammatory myopathies: Clinical sciences
Anatomy clinical correlates: Glossopharyngeal (CN IX), vagus (X), spinal accessory (CN XI) and hypoglossal (CN XII) nerves
Anatomy clinical correlates: Anterior blood supply to the brain
Anatomy clinical correlates: Cerebral hemispheres
Anatomy clinical correlates: Cerebellum and brainstem
Anatomy clinical correlates: Posterior blood supply to the brain
Anatomy clinical correlates: Spinal cord pathways
Anatomy clinical correlates: Vertebral canal
Anatomy clinical correlates: Olfactory (CN I) and optic (CN II) nerves
Anatomy clinical correlates: Oculomotor (CN III), trochlear (CN IV) and abducens (CN VI) nerves
Anatomy clinical correlates: Trigeminal nerve (CN V)
Anatomy clinical correlates: Facial (CN VII) and vestibulocochlear (CN VIII) nerves
Anatomy clinical correlates: Hip, gluteal region and thigh
Anatomy clinical correlates: Median, ulnar and radial nerves
Anatomy clinical correlates: Wrist and hand
Cerebral vascular disease: Pathology review
Demyelinating disorders: Pathology review
Neuromuscular junction disorders: Pathology review
Autosomal trisomies: Pathology review
Congenital neurological disorders: Pathology review
Developmental and learning disorders: Pathology review
Miscellaneous genetic disorders: Pathology review
Vertigo: Pathology review
Movement disorders: Pathology review
Dementia: Pathology review
Central nervous system infections: Pathology review
Headaches: Pathology review
Traumatic brain injury: Pathology review
Vasculitis: Pathology review
Back pain: Pathology review
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Psychological sleep disorders: Pathology review
Urinary incontinence: Pathology review
Myalgias and myositis: Pathology review
Eye conditions: Inflammation, infections and trauma: Pathology review
Eye conditions: Refractive errors, lens disorders and glaucoma: Pathology review
Eye conditions: Retinal disorders: Pathology review
Seizures: Pathology review
Muscular dystrophies and mitochondrial myopathies: Pathology review
Spinal cord disorders: Pathology review
Anatomy of the basal ganglia
Anatomy of the blood supply to the brain
Anatomy of the brainstem
Anatomy of the cerebellum
Anatomy of the cerebral cortex
Anatomy of the cranial base
Anatomy of the cranial meninges and dural venous sinuses
Anatomy of the diencephalon
Anatomy of the limbic system
Anatomy of the ventricular system
Anatomy of the white matter tracts
Bones of the cranium
Anatomy of the external and middle ear
Anatomy of the eye
Anatomy of the inner ear
Development of the face and palate
Development of the nervous system
Development of the eye
Development of the ear
Central nervous system histology
Peripheral nervous system histology
Eye and ear histology
Varicella zoster virus
Serotonin syndrome
Broca aphasia
Wernicke aphasia
Intracerebral hemorrhage
Subarachnoid hemorrhage
Epidural hematoma
Subdural hematoma
Ischemic stroke
Transient ischemic attack
Cerebral palsy
Spina bifida
Bell palsy
Charcot-Marie-Tooth disease
Guillain-Barre syndrome
Sciatica
Alzheimer disease
Multiple sclerosis
Cauda equina syndrome
Vitamin B12 deficiency
Delirium
Huntington disease
Parkinson disease
Fibromyalgia
Trigeminal neuralgia
Seizures and epilepsy
Cranial nerves
Ascending and descending spinal tracts
Anatomy of the abdominal viscera: Kidneys, ureters and suprarenal glands
Anatomy of the urinary organs of the pelvis
Anatomy of the perineum
Anatomy of the male urogenital triangle
Anatomy of the female urogenital triangle
Anatomy clinical correlates: Other abdominal organs
Anatomy clinical correlates: Female pelvis and perineum
Anatomy clinical correlates: Male pelvis and perineum
Development of the renal system
Kidney histology
Ureter, bladder and urethra histology
Chlamydia trachomatis
Neisseria gonorrhoeae
Bladder exstrophy
Horseshoe kidney
Hydronephrosis
Hypospadias and epispadias
Potter sequence
Renal agenesis
Hypercalcemia
Hyperkalemia
Hypermagnesemia
Hypernatremia
Hyperphosphatemia
Hypocalcemia
Hypokalemia
Hypomagnesemia
Hyponatremia
Hypophosphatemia
Acute pyelonephritis
Chronic pyelonephritis
Lower urinary tract infection
Lupus nephritis
Diabetic nephropathy
Chronic kidney disease
Kidney stones
Angiomyolipoma
Medullary cystic kidney disease
Non-urothelial bladder cancers
Nephroblastoma (Wilms tumor)
Renal cell carcinoma
Transitional cell carcinoma
Urinary incontinence
Renal artery stenosis
Acid-base disturbances: Pathology review
Electrolyte disturbances: Pathology review
Urinary tract infections: Pathology review
Renal failure: Pathology review
Renal tubular acidosis: Pathology review
Kidney stones: Pathology review
Renal tubular defects: Pathology review
Renal and urinary tract masses: Pathology review
ACE inhibitors, ARBs and direct renin inhibitors
Carbonic anhydrase inhibitors
Loop diuretics
Osmotic diuretics
Potassium sparing diuretics
Thiazide and thiazide-like diuretics
Acid-base map and compensatory mechanisms
Buffering and Henderson-Hasselbalch equation
Physiologic pH and buffers
The role of the kidney in acid-base balance
Metabolic acidosis
Plasma anion gap
Respiratory acidosis
Metabolic alkalosis
Respiratory alkalosis
Renal system anatomy and physiology
Glomerular filtration
Measuring renal plasma flow and renal blood flow
Regulation of renal blood flow
Renal clearance
TF/Px ratio and TF/Pinulin
Phosphate, calcium and magnesium homeostasis
Potassium homeostasis
Sodium homeostasis
Erythropoietin
Vitamin D
Antidiuretic hormone
Distal convoluted tubule
Loop of Henle
Proximal convoluted tubule
Urea recycling
Renin-angiotensin-aldosterone system
Polycystic kidney disease
Approach to cystic kidney disease: Clinical sciences
Chronic kidney disease: Clinical sciences
Lower urinary tract infection: Clinical sciences
Nephritic syndromes: Pathology review
Nephrotic syndromes: Pathology review
Rapidly progressive glomerulonephritis
IgA nephropathy (NORD)
Membranoproliferative glomerulonephritis
Poststreptococcal glomerulonephritis
Goodpasture syndrome
Prerenal acute kidney injury: Clinical sciences
Intrinsic acute kidney injury (glomerular causes): Clinical sciences
Approach to acute kidney injury: Clinical sciences

Decision-Making Tree

Transcript

Watch video only

Neuromuscular junction disorders are characterized by muscle weakness due to abnormal synaptic neurotransmission of acetylcholine. The underlying pathology can be at the presynaptic membrane, such as impaired vesicular release of acetylcholine; within the synaptic cleft itself, such as decreased breakdown of acetylcholine; or at the postsynaptic membrane, such as a reduction in acetylcholine receptors.

Some important conditions associated with abnormal synaptic neurotransmission of acetylcholine include myasthenia gravis, Lambert-Eaton myasthenic syndrome, botulism, and organophosphate toxicity.

Now, if your patient presents with a chief concern suggestive of a neuromuscular junction disorder, first perform an ABCDE assessment to determine if they are unstable or stable. If unstable, stabilize their airway, breathing, and circulation. At this point, you might need to provide noninvasive positive pressure ventilation or mechanical ventilation. Next, obtain IV access, and don’t forget to put your patient on continuous vital signs monitoring, including heart rate, blood pressure, and pulse oximetry.

Now, here’s a clinical pearl to keep in mind! Patients with a neuromuscular junction disorder may have diaphragm weakness, which can lead to respiratory failure.

In this case, be sure to perform bedside pulmonary function tests, which will reveal reduced vital capacity, which is the amount of air someone can exhale after a maximum inhalation. Also, you will notice reduced maximal inspiratory pressure, which is known as negative inspiratory force, and reduced maximal expiratory pressure. If vital capacity is less than 20 milliliters per kilogram, maximal inspiratory pressure is less than 30 centimeters of water, and maximal expiratory pressure is less than 40 centimeters of water, you should consider intubating the patient. This is known as the 20, 30, 40 rule to guide intubation timing in patients with neuromuscular weakness.

Okay, let’s go back to the ABCDE assessment and take a look at stable patients. If your patient is stable, first obtain a focused history and physical exam, and labs, including complete blood count, comprehensive metabolic panel, creatine kinase, and thyroid stimulating hormone. History will typically reveal painless muscle weakness and ocular symptoms, such as double vision and eyelid drooping.

Additionally, the patient will often report symptoms associated with bulbar involvement, like change in their voice, slurred speech, and difficulty chewing or swallowing. Next, the physical exam will reveal cranial nerve palsies, such as ptosis, impaired extraocular movements, and facial weakness. Also, you will notice neck and limb weakness with a normal sensory exam. Finally, the complete blood count, comprehensive metabolic panel, creatine kinase, and thyroid stimulating hormone will be normal.

These findings are highly suggestive of neuromuscular junction disorder, so your next step is to assess whether there are fluctuations in weakness. If fluctuating weakness is present, assess the patient further to determine whether the underlying cause is myasthenia gravis or Lambert-Eaton myasthenic syndrome.

First, let’s focus on myasthenia gravis, which is associated with muscle weakness that is worse with repeated use, and at the end of the day, but improves after rest. The physical exam will reveal ocular, facial, and bulbar muscle weakness that is worse with repeated use. For example, you will notice ptosis with sustained upgaze, reduced ability to keep cheeks puffed with air, and dysarthria or hypophonia when counting from 1 to 50.

Next, you will find proximal greater than distal limb weakness, such as shoulder abduction weakness, which worsens when the patient repeatedly raises their arms over their head. Deep tendon reflexes will be normal. Finally, if there is ptosis, perform an ice pack test by applying a bag of ice to the eyelid for 2 minutes, since cold temperature can improve neuromuscular transmission. If the symptoms improve, the ice pack test is positive.

With these findings, you should consider myasthenia gravis and test for serum antibodies that affect the postsynaptic transmission of acetylcholine. These include anti-acetylcholine receptor antibodies, anti-muscle-specific kinase antibodies, and anti-low-density lipoprotein receptor-related protein 4 antibodies. If any of these antibodies are positive, diagnose myasthenia gravis.

However, if these antibodies are negative, order a nerve conduction study with repetitive nerve stimulation and a single-fiber electromyography. A nerve conduction study measures how well an electrical signal is traveling through a motor or sensory nerve, while electromyography evaluates the electrical activity generated by muscles, both at rest and with activation.

If the nerve conduction study reveals a decremental response in the amplitude of compound muscle action potentials to repetitive nerve stimulation, and the single-fiber electromyography shows increased jitter, which is increased asynchronous firing of muscle fibers innervated by the same motor neuron, diagnose myasthenia gravis even in the absence of antibodies.

Next, let’s take a look at individuals with Lambert-Eaton myasthenic syndrome! In this case, history will reveal muscle weakness that is better with repeated use and improves at the end of the day. The patient might report symptoms consistent with autonomic dysfunction, such as dry eyes and mouth, constipation, and urinary incontinence. Also, history might reveal active cancer, particularly small cell lung cancer, but other types of malignancy are possible as well.

On exam, patients will present with orthostatic hypotension, proximal greater than distal limb weakness that is better with repeated use and decreased or absent deep tendon reflexes. They might also have dilated and poorly reactive pupils. With these findings, suspect Lambert-Eaton myasthenic syndrome.

Next, order voltage-gated calcium channel antibodies, which block presynaptic calcium channels, leading to decreased release of acetylcholine from presynaptic vesicles into the synaptic cleft. In addition, order a nerve conduction study and electromyography.

If voltage-gated calcium channel antibodies are positive, particularly against the P/Q voltage-gated calcium channels, nerve conduction study with repetitive nerve stimulation shows an incremental response in the compound muscle action potential after briefly exercising the muscle being tested, and electromyography shows normal or small compound muscle action potentials, diagnose Lambert-Eaton myasthenic syndrome.

Sources

  1. "Clinical guidelines for diagnosis and treatment of botulism" MMWR Recomm Rep (2021)
  2. "Neuromuscular disorders in the intensive care unit" Continuum (Minneap Minn) (2021)
  3. "Diagnosis and management of myasthenia gravis" Continuum (Minneap Minn) (2022)
  4. "Organophosphorus nerve agent poisoning: managing the poisoned patient" Br J Anaesth (2019)
  5. "Lambert-Eaton myasthenic syndrome and botulism" Br J Anaesth (2022)
  6. "A Symptoms and signs approach to the patient with neuromuscular weakness" Continuum (Minneap Minn) (2022)